TP53 and hepatocellular carcinoma: Further delineation of the E2-signaling mechanism in regulating the activation of p53 and miR-23a expression in HCC will be crucial to the understanding of the sex difference observed in this disease entity, and may provide a new avenue for the development of more efficient therapeutic strategies and treatment.